U.S. markets open in 7 hours 52 minutes

Phreesia, Inc. (PHR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
37.99-1.00 (-2.56%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close38.99
Open38.15
Bid0.00 x 800
Ask0.00 x 800
Day's Range37.26 - 38.65
52 Week Range16.01 - 39.31
Volume373,333
Avg. Volume475,306
Market Cap1.661B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.50
Earnings DateSep 09, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est36.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Benzinga's Top Upgrades, Downgrades For October 27, 2020

    Upgrades * According to UBS, the prior rating for United Parcel Service Inc (NYSE: UPS) was changed from Neutral to Buy. In the second quarter, United Parcel Service showed an EPS of $2.13, compared to $1.96 from the year-ago quarter. The current stock performance of United Parcel Service shows a 52-week-high of 178.01 and a 52-week-low of 82.0. Moreover, at the end of the last trading period, the closing price was at $167.90. * According to JP Morgan, the prior rating for NCR Corp (NYSE: NCR) was changed from Neutral to Overweight. For the third quarter, NCR had an EPS of No EPS Value , compared to year-ago quarter EPS of $0.73. The stock has a 52-week-high of 35.87 and a 52-week-low of 10.55. At the end of the last trading period, NCR closed at $21.09. * According to Morgan Stanley, the prior rating for Xenia Hotels & Resorts Inc (NYSE: XHR) was changed from Underweight to Equal-Weight. For the second quarter, Xenia Hotels & Resorts had an EPS of $0.46, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of 22.39 and a 52-week-low of 6.145. At the end of the last trading period, Xenia Hotels & Resorts closed at $9.03. * Morgan Stanley upgraded the previous rating for Diamondrock Hospitality Co (NYSE: DRH) from Underweight to Equal-Weight. Diamondrock Hospitality earned $0.20 in the second quarter, compared to $0.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of 11.79 and a 52-week-low of 1.96. Diamondrock Hospitality closed at $5.03 at the end of the last trading period. * Raymond James upgraded the previous rating for Corporate Office Properties Trust (NYSE: OFC) from Market Perform to Outperform. In the second quarter, Corporate Office Props showed an EPS of $0.51, compared to $0.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of 30.57 and a 52-week-low of 15.23. Corporate Office Props closed at $23.51 at the end of the last trading period. * According to Oppenheimer, the prior rating for Boingo Wireless Inc (NASDAQ: WIFI) was changed from Perform to Outperform. In the second quarter, Boingo Wireless showed an EPS of $0.13, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of 15.92 and a 52-week-low of 6.66. At the end of the last trading period, Boingo Wireless closed at $8.76. * For ADT Inc (NYSE: ADT), Citigroup upgraded the previous rating of Neutral to the current rating Buy. ADT earned $0.07 in the second quarter, compared to $0.02 in the year-ago quarter. The current stock performance of ADT shows a 52-week-high of 17.21 and a 52-week-low of 3.405. Moreover, at the end of the last trading period, the closing price was at $7.38. Downgrades * Oppenheimer downgraded the previous rating for Catabasis Pharmaceuticals Inc (NASDAQ: CATB) from Outperform to Perform. In the second quarter, Catabasis Pharmaceuticals showed an EPS of $0.53, compared to $0.62 from the year-ago quarter. The stock has a 52-week-high of 8.59 and a 52-week-low of 2.74. At the end of the last trading period, Catabasis Pharmaceuticals closed at $5.36. * According to HC Wainwright & Co., the prior rating for Catabasis Pharmaceuticals Inc (NASDAQ: CATB) was changed from Buy to Neutral. Catabasis Pharmaceuticals earned $0.53 in the second quarter, compared to $0.62 in the year-ago quarter. The current stock performance of Catabasis Pharmaceuticals shows a 52-week-high of 8.59 and a 52-week-low of 2.74. Moreover, at the end of the last trading period, the closing price was at $5.36. * ScotiaBank downgraded the previous rating for Celanese Corp (NYSE: CE) from Sector Outperform to Sector Perform. Celanese earned $1.95 in the third quarter, compared to $2.53 in the year-ago quarter. The stock has a 52-week-high of 128.875 and a 52-week-low of 52.7. At the end of the last trading period, Celanese closed at $115.52. * For Umpqua Holdings Corp (NASDAQ: UMPQ), JP Morgan downgraded the previous rating of Neutral to the current rating Underweight. In the third quarter, Umpqua Holdings showed an EPS of $0.57, compared to $0.38 from the year-ago quarter. The current stock performance of Umpqua Holdings shows a 52-week-high of 18.94 and a 52-week-low of 8.88. Moreover, at the end of the last trading period, the closing price was at $13.35. * For Primoris Services Corp (NASDAQ: PRIM), KeyBanc downgraded the previous rating of Overweight to the current rating Sector Weight. In the second quarter, Primoris Services showed an EPS of $0.68, compared to $0.35 from the year-ago quarter. At the moment, the stock has a 52-week-high of 23.73 and a 52-week-low of 9.42. Primoris Services closed at $19.73 at the end of the last trading period. Initiations * With a current rating of Buy, Aegis Capital initiated coverage on Jerash Holdings (US) Inc (NASDAQ: JRSH). The price target seems to have been set at $8.00 for Jerash Holdings (US). For the first quarter, Jerash Holdings (US) had an EPS of $0.07, compared to year-ago quarter EPS of $0.14. The current stock performance of Jerash Holdings (US) shows a 52-week-high of 7.145 and a 52-week-low of 3.6. Moreover, at the end of the last trading period, the closing price was at $4.85. * With a current rating of Buy, Small Cap Consumer Research initiated coverage on Betterware de Mexico SAB de CV (NASDAQ: BWMX). The price target seems to have been set at $30.00 for Betterware de Mexico SAB. The current stock performance of Betterware de Mexico SAB shows a 52-week-high of 37.82 and a 52-week-low of 5.67. Moreover, at the end of the last trading period, the closing price was at $24.31. * With a current rating of Buy, Truist Securities initiated coverage on Intellia Therapeutics Inc (NASDAQ: NTLA). The price target seems to have been set at $40.00 for Intellia Therapeutics. Intellia Therapeutics earned $0.61 in the second quarter, compared to $0.56 in the year-ago quarter. The stock has a 52-week-high of 27.07 and a 52-week-low of 9.18. At the end of the last trading period, Intellia Therapeutics closed at $24.50. * With a current rating of Buy, BTIG initiated coverage on Paya Holdings Inc (NASDAQ: PAYA). The price target seems to have been set at $15.00 for Paya Holdings. The current stock performance of Paya Holdings shows a 52-week-high of 12.29 and a 52-week-low of 10.77. Moreover, at the end of the last trading period, the closing price was at $10.92. * Needham initiated coverage on Phreesia Inc (NYSE: PHR) with a Buy rating. The price target for Phreesia is set to $44.00. In the second quarter, Phreesia showed an EPS of $0.08, compared to $1.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.31 and a 52-week-low of 16.01. Phreesia closed at $37.10 at the end of the last trading period. * For Academy Sports and Outdoors Inc (NASDAQ: ASO), Evercore ISI Group initiated coverage, by setting the current rating at Outperform. At the moment, the stock has a 52-week-high of 15.71 and a 52-week-low of 12.05. Academy Sports closed at $14.80 at the end of the last trading period. * BMO Capital initiated coverage on C4 Therapeutics Inc (NASDAQ: CCCC) with an Outperform rating. The price target for C4 Therapeutics is set to $33.00. The stock has a 52-week-high of 28.75 and a 52-week-low of 22.4001. At the end of the last trading period, C4 Therapeutics closed at $26.23. * Jefferies initiated coverage on Oncorus Inc (NASDAQ: ONCR) with a Buy rating. The price target for Oncorus is set to $22.00. The stock has a 52-week-high of 19.3 and a 52-week-low of 14.6. At the end of the last trading period, Oncorus closed at $16.40. * Stephens & Co. initiated coverage on Academy Sports and Outdoors Inc (NASDAQ: ASO) with an Overweight rating. The price target for Academy Sports is set to $17.50. At the moment, the stock has a 52-week-high of 15.71 and a 52-week-low of 12.05. Academy Sports closed at $14.80 at the end of the last trading period. * JP Morgan initiated coverage on Academy Sports and Outdoors Inc (NASDAQ: ASO) with an Overweight rating. The price target for Academy Sports is set to $21.00. The stock has a 52-week-high of 15.71 and a 52-week-low of 12.05. At the end of the last trading period, Academy Sports closed at $14.80. * With a current rating of Buy, Jefferies initiated coverage on Open Lending Corp (NASDAQ: LPRO). The price target seems to have been set at $35.00 for Open Lending. Open Lending earned $0.02 in the second quarter. At the moment, the stock has a 52-week-high of 28.5 and a 52-week-low of 12.7. Open Lending closed at $26.87 at the end of the last trading period. * Piper Sandler initiated coverage on Oncorus Inc (NASDAQ: ONCR) with an Overweight rating. The price target for Oncorus is set to $40.00. The current stock performance of Oncorus shows a 52-week-high of 19.3 and a 52-week-low of 14.6. Moreover, at the end of the last trading period, the closing price was at $16.40. * Piper Sandler initiated coverage on Aptinyx Inc (NASDAQ: APTX) with an Overweight rating. The price target for Aptinyx is set to $10.00. In the second quarter, Aptinyx showed an EPS of $0.27, compared to $0.36 from the year-ago quarter. The current stock performance of Aptinyx shows a 52-week-high of 6.47 and a 52-week-low of 1.6. Moreover, at the end of the last trading period, the closing price was at $2.98. * With a current rating of Buy, Chardan Capital initiated coverage on Immunome Inc (NASDAQ: IMNM). The price target seems to have been set at $18.00 for Immunome. The stock has a 52-week-high of 16.77 and a 52-week-low of 11.54. At the end of the last trading period, Immunome closed at $12.20.See more from Benzinga * Click here for options trades from Benzinga * What Does Microsoft's Debt Look Like? * Exact Sciences's Debt Overview(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Phreesia’s Kristin Roberts Named a Top Woman Leader in SaaS
    Business Wire

    Phreesia’s Kristin Roberts Named a Top Woman Leader in SaaS

    Phreesia, the nation’s leading patient intake platform, is pleased to announce that Kristin Roberts, the company’s Vice President of Market Development, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2020.

  • Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    Business Wire

    Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

    Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,750,000 shares of its common stock (the "Offering"), all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares of common stock. The shares were sold at a public offering price of $32.00 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount.